FDA approves first new drug for schizophrenia in more than 30 years
(SILVER SPRING, Md.) -- The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years.Cobenfy, manufactured by Bristol Myers Squibb, combines two drugs, xanomeline and trospium chloride, and is taken as...
